IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Physiopathological Study of Autonomic Failure in Parkinson's Disease (SYNAPark)
This study has been completed.
Sponsor:
Nantes University Hospital
Information provided by (Responsible Party):
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT01748409
First received: December 10, 2012
Last updated: October 4, 2016
Last verified: October 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study is to evaluate the autonomic failure in Parkinson's disease by clinical, electrophysiological and neuropathological examination.
| Condition | Intervention |
|---|---|
| Parkinson's Disease | Other: Biopsies of peripheral autonomic nervous system Other: Autonomic dysfunction questionnaires Other: Electrophysiological tests |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Health Services Research |
| Official Title: | Physiopathological Study of Autonomic Failure in Parkinson's Disease : a Monocentric Study |
Resource links provided by NLM:
Genetics Home Reference related topics:
Parkinson disease
MedlinePlus related topics:
Parkinson's Disease
U.S. FDA Resources
Further study details as provided by Nantes University Hospital:
Primary Outcome Measures:
- Evaluate association between clinical autonomic failure and neuropathological autonomic failure on biopsies. [ Time Frame: 3 months ]
the main objective is to look after associations between :
- anatomopathological signs of autonomic nervous system disorders seen on biopsies AND
- clinical signs of signs of autonomic nervous system disorders seen through functional tests or through symptoms indicated by the patient on questionaries.
Secondary Outcome Measures:
- Evaluate association between autonomic failure and severity factors in Parkinson's disease [ Time Frame: 3 months ]
Autonomic failure will be assessed through questionaries on symptoms and through functional tests.
Severity factors in parkinson disease will refer to various parameters like patient age.
- Evaluate consequences of autonomic failure on quality of life and sleep quality [ Time Frame: 3 months ]quality of life and of sleep will be assessed through functional tests and through questionaries.
| Enrollment: | 47 |
| Study Start Date: | February 2013 |
| Study Completion Date: | March 2016 |
| Primary Completion Date: | March 2016 (Final data collection date for primary outcome measure) |
Intervention Details:
-
Other: Biopsies of peripheral autonomic nervous system
Other: Autonomic dysfunction questionnaires
Other Name: a battery of questionaries to evaluate autonomic neurological patient complaints and dysfunctions.
Other: Electrophysiological tests
Other Name: A battery of electrophysiological tests to assess neurological functions
Eligibility| Ages Eligible for Study: | 45 Years to 80 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients with Parkinson's disease
- ages 45 to 80 years, both genders
- patients who signed informed consent
Exclusion Criteria:
- autonomic function modifying treatment
- pre-existing neuropathy or risk factors for neuropathy
- dementia
- colonic disorders
- coagulation disorders (may be due to treatment)
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01748409
Please refer to this study by its ClinicalTrials.gov identifier: NCT01748409
Locations
| France | |
| Nantes Universitary Hospital | |
| Nantes, Loire Atlantique, France, 44093 | |
Sponsors and Collaborators
Nantes University Hospital
More Information
| Responsible Party: | Nantes University Hospital |
| ClinicalTrials.gov Identifier: | NCT01748409 History of Changes |
| Other Study ID Numbers: |
RC12_0264 |
| Study First Received: | December 10, 2012 |
| Last Updated: | October 4, 2016 |
Keywords provided by Nantes University Hospital:
|
Autonomic failure, Parkinson's disease, electrophysiological assessment, neuropathological assessment |
Additional relevant MeSH terms:
|
Parkinson Disease Pure Autonomic Failure Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Movement Disorders Neurodegenerative Diseases Primary Dysautonomias Autonomic Nervous System Diseases |
ClinicalTrials.gov processed this record on September 21, 2017